2Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol, 1994,87 : 503-508.
二级参考文献7
1Bertolini F, Mancuso P, Gobbi A, et al. The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol,2000,28:993-1000.
2Mangi MH, Newland AC. Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol, 2000,111:43-51.
3Singhal S, Mehta J, Desikan R,et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med,1999,341:1565-1571.
4Vacca A, Ribatti D, Roncali L,et al.Bone marrow angiogenesis and progression in multiple myeloma.Br J Haematol,1994,87:503-508.
5Rajkumar SV, Leong T, Roche PC,et al.Prognostic value of bone marrow angiogenesis in multiple myeloma.Clin Cancer Res, 2000,6:3111-3116.
6Hideshima T,Chauhan D, Shima Y, et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood,2000,96:2943-2950.
